ARTICLE | Company News
Amarantus BioSciences Inc., Banyan Biomarkers deal
December 5, 2011 8:00 AM UTC
Amarantus partnered with Banyan to develop Amarantus' mesencephalic astrocyte-derived neurotrophic factor (MANF; ARP; ARMET)-based technology to treat traumatic brain injury (TBI). Banyan will conduc...